Pneumonia can be serious. Vaccines offer protection!

Pneumonia Vaccine Research studies are enrolling now!

Those who qualify may receive*:

  • Payment up to $170, which varies by study
  • Study-related care at no cost from local doctors
  • Study medication at no cost

Ready to get started? Click Here.

Pneumococcal pneumonia, a kind of pneumonia, can infect the upper respiratory tract and can spread to the blood, lungs, middle ear, or nervous system. Pneumonia is most serious for infants and young children, people older than age 65, and people with health problems or weakened immune systems.

Bacteria in the air we breathe is one of the most common causes of pneumonia. Your body usually prevents these germs from infecting your lungs. But sometimes these germs can overpower your immune system, even if your health is generally good.

Vaccination is the safest and most effective way to protect yourself. When enough people are vaccinated, the germs that cause pneumonia cannot travel as easily from person to person since the number of people who could pass along the bacteria or viruses are reduced. This is called community immunity or herd immunity. That means – the more people who are vaccinated against a disease like pneumonia, the more protection provided to an entire community of people.

There is a need for vaccines that protect against a wider array of bacteria that could result in infection. Researchers are evaluating a study vaccine that may be able to offer protection, and they need healthy volunteers age 18 and older. If you are 65 and older, you still may qualify even if you’ve had one or both of the currently available vaccines. Your risk for pneumonia increases with age, so take the next step toward prevention.

Protect yourself and you can protect others!

Take the next step to see if you qualify for local pneumonia vaccine research studies for otherwise healthy people. But don’t delay — space is limited!

* In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. Reasonable payments will be made for participation and the length of the study may vary.

Ready to get started?

Click Here.

How does it work?


Tell us a little bit about yourself


Answer some questions about your health


We will connect you to available studies in your area

Just takes a few minutes


AcurianHealth helps connect people with clinical research studies that offer treatments under development. We carefully match thousands of people to hundreds of research studies all over the world.